CCN5 mitigates myosteatosis and counteracts sarcopenia by promoting mitochondrial biogenesis and enhancing LD-Mt interactions through dual pathways, positioning it as a promising therapeutic target for muscle aging and sarcopenia.
Building similarity graph...
Analyzing shared references across papers
Loading...
Shen et al. (Wed,) studied this question.
synapsesocial.com/papers/69d8946e6c1944d70ce0553e — DOI: https://doi.org/10.1002/jcsm.70282
Zile Shen
Shanghai East Hospital
Zhang Liu
Wuhan University
Guowei Huang
Shanghai Tenth People's Hospital
Journal of Cachexia Sarcopenia and Muscle
Tongji University
Wenzhou Medical University
Shanghai Tenth People's Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: